Brain Tumor Pathology

, Volume 15, Issue 1, pp 53–57 | Cite as

Function of aberrant EGFR in malignant gliomas

  • Noriaki Sugawa
  • Kazuaki Yamamoto
  • Satoshi Ueda
  • Noriyuki Morita
  • Masahide Kita
  • Hoyoku Nishino
  • Shinji Fushiki
  • Toshihide Okabe
Original Article


The most common alteration of the epidermal growth factor receptor (EGFR) gene in human malignant gliomas is an in-frame deletion of exon 2–7 from the extracellular domain. To study the relationship between the expression of this aberrant EGFR and cell proliferation, as well as apoptosis in malignant gliomas, we have developed U-87MG cell transfectants that express the aberrant (mutant-type) or normal (wild-type) EGFR. We analyzed cell number, tumor volume, and MIB-1 positive rate as proliferation markers, and found that in tissue culture, tumors derived from U-87 MG cells (mutant-type) have the same proliferative activity as those derived from U-87 MG cells (wild-type). However, when cells expressing mutant EGFR were implanted into nude mice subcutaneously, the tumorigenic capacity was much enhanced. We also found that the apototic index of tumors derived from U-87 MG cells (mutant-type) was less than 0.1%, whereas that of wild-type tumor was 1%. These results suggest that aberrant EGFR affects the malignancy of glioma by stimulating proliferation and inhibiting apoptosis.

Key words

Glioma Aberrant EGFR Xenograftic tumor MB-1 Apoptosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Devaux B, O'Fallon J, Kelly P (1993) Resection, biopsy, and survival in malignant glial neoplasms. J Neurosurg 78:767–775PubMedCrossRefGoogle Scholar
  2. 2.
    Kreth F, Warnke P, Scheremet R et al. (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766PubMedGoogle Scholar
  3. 3.
    Lund-Johansen M, Forsberg K, Bjerkvig R et al. (1992) Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 84:190–197PubMedCrossRefGoogle Scholar
  4. 4.
    Ekstrand AJ, Longo N, Hamid ML et al. (1994) Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9:2313–2320PubMedGoogle Scholar
  5. 5.
    Libermann TA, Razon N, Bartal AD et al. (1984) Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44:753–760PubMedGoogle Scholar
  6. 6.
    Xu YH, Richert N, Ito S et al. (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81:7308–7312PubMedCrossRefGoogle Scholar
  7. 7.
    Nister M, Libermann TA, Betzholtz C et al. (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48:3910–3918PubMedGoogle Scholar
  8. 8.
    Panayotou G, Waterfield M (1993) The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 15:171–177PubMedCrossRefGoogle Scholar
  9. 9.
    Aaronson S (1991) Growth factors and cancer. Science 254:1146–1153PubMedGoogle Scholar
  10. 10.
    Barrandon Y, Green H (1987) Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell 50:1131–1137PubMedCrossRefGoogle Scholar
  11. 11.
    Westermark B, Magnusson A, Heldin C (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8:491–507PubMedCrossRefGoogle Scholar
  12. 12.
    Di Fiore PP, Pierce JM, Fleming TP et al. (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063–1070PubMedCrossRefGoogle Scholar
  13. 13.
    Downward J, Yarden Y, Mayes E et al. (1984) Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521–527PubMedCrossRefGoogle Scholar
  14. 14.
    Garcia de Palazzo I, Adams G, Sundareshan P et al. (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 53:3217–3220PubMedGoogle Scholar
  15. 15.
    Khazaie K, Schirrmacher V, Lichtner R (1993) EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12:255–274PubMedCrossRefGoogle Scholar
  16. 16.
    Sugawa N, Ekstrand AJ, James CD et al. (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602–8606PubMedCrossRefGoogle Scholar
  17. 17.
    Ekstrand J, Sugawa N, James CD et al. (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89:4309–4313PubMedCrossRefGoogle Scholar
  18. 18.
    Wong AJ, Ruppert JM, Bigner SH et al. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89:2965–2969PubMedCrossRefGoogle Scholar
  19. 19.
    Ullrich A, Coossens L, Hayflick JS et al. (1984) Human epidermal growth factor receptor cDNA sequencek 2 and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309(5967):418–425PubMedCrossRefGoogle Scholar
  20. 20.
    DiPersio L, Kyriazis AP, Michael JG et al. (1979) Monitoring the therapy of human tumor xenografts in nude mice by the use of lactate dehydrogenase. J Natl Cancer Inst 62:375–379PubMedGoogle Scholar
  21. 21.
    Taetle R, Rosen F, Abramson I et al. (1987) Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep 71:297–304PubMedGoogle Scholar
  22. 22.
    Noonan KE, Roninson IB (1988) mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res 16:10366PubMedGoogle Scholar
  23. 23.
    Ide M, Jimbo M, Yamamoto M et al. (1996) MIB-1 staining index and peritumoral brain edema of meningioma. Cancer 78:133–143PubMedCrossRefGoogle Scholar
  24. 24.
    Yamazaki H, Fukui Y, Ueyama Y et al. (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8:1816–1820PubMedGoogle Scholar
  25. 25.
    Nishikawa R, Ji XD, Harmon RC et al. (1994) A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91:7727–7731PubMedCrossRefGoogle Scholar
  26. 26.
    Ekstrand A, Liu L, Hamid M et al. (1995) Altered subcellular location of an activated and tumor-associated epidermal growth factor receptor. Oncogene 10:2313–2320Google Scholar
  27. 27.
    Nakagawa S, Shiraishi T, Kihara S et al. (1995) Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch 427:175–179PubMedCrossRefGoogle Scholar
  28. 28.
    Leoncini L, Vecchio M, Megha T et al. (1993) Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142:755–763PubMedGoogle Scholar
  29. 29.
    Nagane M, Coufal F, Lin H et al. (1996) A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56:5079–5086PubMedGoogle Scholar
  30. 30.
    Englert C, Hou X, Maheswaran S et al. (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. Embo J 14:4662–4675PubMedGoogle Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 1998

Authors and Affiliations

  • Noriaki Sugawa
    • 1
  • Kazuaki Yamamoto
    • 2
  • Satoshi Ueda
    • 2
  • Noriyuki Morita
    • 3
  • Masahide Kita
    • 4
  • Hoyoku Nishino
    • 5
  • Shinji Fushiki
    • 6
  • Toshihide Okabe
    • 7
  1. 1.Department of NeurosurgeryKyoto Prefectural Yosanoumi HospitalKyotoJapan
  2. 2.Department of NeurosurgeryKyoto Prefectural University of MedicineKyotoJapan
  3. 3.Department of First AnatomyKyoto Prefectural University of MedicineKyotoJapan
  4. 4.Department of MicrobiologyKyoto Prefectural University of MedicineKyotoJapan
  5. 5.Department of BiochemistryKyoto Prefectural University of MedicineKyotoJapan
  6. 6.Research Institute for Neurogical Disease and GeviatricsKyotoJapan
  7. 7.Department of Clinical PathologyShiga Medical UniversityShigaJapan

Personalised recommendations